000			01919 a2200517 4500
005			20250515225000.0
264		0	_c20100907
008			201009s 0 0 eng d
022			_a1932-6203
024	7		_a10.1371/journal.pone.0010800 _2doi
040			_aNLM _beng _cNLM
100	1		_aBrandl, Carolin
245	0	0	_aB7-H1-deficiency enhances the potential of tolerogenic dendritic cells by activating CD1d-restricted type II NKT cells. _h[electronic resource]
260			_bPloS one _cMay 2010
300			_ae10800 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntigens, CD1d _ximmunology
650	0	4	_aAntigens, Surface _xmetabolism
650	0	4	_aApoptosis Regulatory Proteins _xmetabolism
650	0	4	_aB7-1 Antigen _xmetabolism
650	0	4	_aB7-H1 Antigen
650	0	4	_aBiomarkers _xmetabolism
650	0	4	_aCD4-Positive T-Lymphocytes _xdrug effects
650	0	4	_aCell Line
650	0	4	_aCell Membrane _xdrug effects
650	0	4	_aCentral Nervous System _xdrug effects
650	0	4	_aDendritic Cells _xdrug effects
650	0	4	_aEncephalomyelitis, Autoimmune, Experimental _ximmunology
650	0	4	_aEpitopes _ximmunology
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMembrane Glycoproteins _xdeficiency
650	0	4	_aMice
650	0	4	_aNatural Killer T-Cells _xdrug effects
650	0	4	_aOrganic Chemicals _ximmunology
650	0	4	_aPeptides _xdeficiency
650	0	4	_aProgrammed Cell Death 1 Receptor
650	0	4	_aTumor Necrosis Factor-alpha _xadministration & dosage
700	1		_aOrtler, Sonja
700	1		_aHerrmann, Thomas
700	1		_aCardell, Susanna
700	1		_aLutz, Manfred B
700	1		_aWiendl, Heinz
773	0		_tPloS one _gvol. 5 _gno. 5 _gp. e10800
856	4	0	_uhttps://doi.org/10.1371/journal.pone.0010800 _zAvailable from publisher's website
999			_c19871516 _d19871516